Home › Knee Osteoarthritis › NCT05495334

Innovations in Genicular Outcomes Registry

Who can join

All ages · All sexes

Inclusion Criteria:

1. Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
2. Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator
3. Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application

Exclusion Criteria:

1. Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol
2. Planning to have a surgery other than on the target knee

About the study

The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).

What is being tested

• Treatment for Knee OA (procedure)

Sponsor: Pacira Pharmaceuticals, Inc · Participants: 10,000 · Started: Sep 23, 2021

Contact the study team

• Kate Fasel, BSN · Phone: 1-520-490-5355

Official record on ClinicalTrials.gov — NCT05495334

Locations in the U.S.

Conditions

• Knee Osteoarthritis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.